Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

0.7609 -0.0211 (-2.70%)
Streaming Delayed Price Updated: 3:59 PM EST, Mar 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
UCLA Researchers Develop Method to Fix Fuel Shortages in Cancer Immunotherapy
Via Investor Brand Network
Engineered Nanoparticles Hold Promise in Delivering Precision Cancer Treatments
Via Investor Brand Network
Cancer Stress Protein Enables Tumors to Evade the Immune System
Via Investor Brand Network
Existing Cancer Drug Shows Potential in Reactivating Immunotherapy
Via Investor Brand Network
Early Symptoms of Lung Cancer You Could Be Ignoring
Via Investor Brand Network
Novel Yeast Cell Platform Promises to Expedite the Development of Immunotherapies
Via Investor Brand Network
Scientists Discover Why Immunotherapy Frequently Fails
Via Investor Brand Network
Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy
Via Investor Brand Network
Circadian Regulation Could Boost Cancer Immunotherapy, New Study Finds
Via Investor Brand Network
Novel Therapy Helps Tumor Cells Welcome Cancer Treatment
Via Investor Brand Network
Scientists Develop Next-Gen Antibodies That Boost the Body’s Cancer Killing Cells
Via Investor Brand Network
Study Discovers Molecule of Gut Bacteria That Boosts Immunotherapy Response
Via Investor Brand Network
Cornell Researchers Develop Particles That Can Supercharge Immunotherapy
Via Investor Brand Network
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
Via Chartmill
New ‘Nanozigzag’ Biomaterial Shows Potential in Revolutionizing Cancer Immunotherapy
Via Investor Brand Network
New Approach Could Increase Response Rates for Cancer Immunotherapy
Via Investor Brand Network
Novel Biomarker Could Predict Resistance to Immunotherapy, Study Finds
Via Investor Brand Network
Study Highlights Increasing Cases of Breast Cancer in Younger Women
Via Investor Brand Network
Study Proposes Overhaul of US Lung Cancer Screening Guidelines
Via Investor Brand Network
News headline image
Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
Cancer Immunotherapy Could Be Boosted by Targeting Pathways of DNA Repair
Via Investor Brand Network
What Patients Need to Know About Exercising During Cancer Treatment
Via Investor Brand Network
Study identifies Biomarker to Predict Success of Immunotherapy, Chemo for Breast Cancer
Via Investor Brand Network
Rarest Natural Element Promises to Revolutionize How Cancer is Treated
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
Cancer Immunotherapy Could Be Transformed by Boosting Natural Killer Cells
Via Investor Brand Network
Lung Cancer Screening is Still Woefully Low in the US, Report Shows
Via Investor Brand Network
Topics Death
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues
Via Investor Brand Network
Researchers Urge Canadians to Donate Toenails, for Science
Via Investor Brand Network
Researchers Discover Why Cancer Immunotherapy Could Be Failing
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.